Biogen Inc.
BIIB | NASDAQ
$248.81
-$4.81 (-1.90%)
Nov 2, 2026, 1:41 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 3.01B | 2.38B | 1.05B | 3.42B | 2.26B | 1.33B |
Short-Term Investments | 807.2M | n/a | n/a | 1.47B | 1.54B | 1.28B |
Long-Term Investments | 750.6M | 226.7M | 460.7M | 705.7M | 892M | 772.1M |
Other Long-Term Assets | 431.9M | 333.8M | 284.3M | 1.53B | 1.94B | 2.9B |
Receivables | 1.87B | 1.87B | 2.1B | 2.14B | 1.96B | 2.33B |
Inventory | 2.17B | 2.46B | 2.53B | 1.34B | 1.35B | 1.07B |
Other Current Assets | 1.12B | 752.5M | 1.18B | 1.42B | 740.8M | 881.1M |
Total Current Assets | 8.97B | 7.46B | 6.86B | 9.79B | 7.86B | 6.89B |
Property-Plant & Equipment | 3.32B | 3.54B | 3.73B | 3.7B | 3.79B | 3.84B |
Goodwill & Intangibles | 15.67B | 16.17B | 14.58B | 7.6B | 7.98B | 8.85B |
Total Long-Term Assets | 20.47B | 20.59B | 19.99B | 14.76B | 16.02B | 17.73B |
Total Assets | 29.44B | 28.05B | 26.84B | 24.55B | 23.88B | 24.62B |
Account Payables | 432M | 424.2M | 403.3M | 491.5M | 589.2M | 454.9M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 80.4M | 1.75B | 150M | n/a | 999.1M | n/a |
Other Current Liabilities | 2.72B | 375.8M | 335.1M | 1.14B | 345.1M | 515.3M |
Total Current Liabilities | 3.35B | 5.53B | 3.43B | 3.27B | 4.3B | 3.74B |
Long-Term Debt | 6.58B | 4.55B | 6.79B | 6.28B | 6.27B | 7.43B |
Other Long-Term Liabilities | 458.1M | 732.3M | 781.1M | 944.2M | 1.32B | 1.33B |
Total Long-Term Liabilities | 7.83B | 5.8B | 8.61B | 7.89B | 8.62B | 10.19B |
Total Liabilities | 11.18B | 11.33B | 12.05B | 11.17B | 12.92B | 13.93B |
Total Debt | 6.95B | 6.63B | 7.34B | 6.61B | 7.6B | 7.83B |
Book Value | 18.26B | 16.72B | 14.8B | 13.39B | 10.96B | 10.69B |
Book Value Per Share | 124.45 | 114.57 | 101.64 | 91.70 | 73.26 | 66.25 |
Common Stock | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | 20.55B | 19.26B | 17.63B | 16.47B | 13.91B | 13.98B |
Comprehensive Income | -182M | -136.2M | -153.7M | -164.9M | -106.7M | -299M |
Shareholders Equity | 18.26B | 16.72B | 14.8B | 13.4B | 10.9B | 10.7B |
Total Investments | 1.56B | 226.7M | 460.7M | 2.18B | 2.43B | 2.05B |
Add to Watchlist
Select watchlists to add or remove BIIB